Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Income from Non-Controlling Interests (2016 - 2025)

Historic Income from Non-Controlling Interests for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $15.4 million.

  • Select Medical Holdings' Income from Non-Controlling Interests fell 3939.02% to $15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.6 million, marking a year-over-year decrease of 999.76%. This contributed to the annual value of $82.7 million for FY2024, which is 4698.79% up from last year.
  • Latest data reveals that Select Medical Holdings reported Income from Non-Controlling Interests of $15.4 million as of Q3 2025, which was down 3939.02% from $17.3 million recorded in Q2 2025.
  • In the past 5 years, Select Medical Holdings' Income from Non-Controlling Interests ranged from a high of $31.3 million in Q2 2021 and a low of $6.8 million during Q1 2022
  • Its 5-year average for Income from Non-Controlling Interests is $17.2 million, with a median of $16.5 million in 2021.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first crashed by 7446.75% in 2022, then surged by 11224.85% in 2023.
  • Select Medical Holdings' Income from Non-Controlling Interests (Quarter) stood at $16.5 million in 2021, then plummeted by 37.96% to $10.2 million in 2022, then surged by 52.13% to $15.5 million in 2023, then grew by 27.54% to $19.8 million in 2024, then decreased by 22.31% to $15.4 million in 2025.
  • Its Income from Non-Controlling Interests stands at $15.4 million for Q3 2025, versus $17.3 million for Q2 2025 and $18.1 million for Q1 2025.